High-plex solutions that leverage proteomics to advance understanding of Alzheimer’s disease
Check out these opportunities to learn about high-plex protein profiling with the SomaScan® Assay
Join us at AAIC 2024 in Philadelphia, Booth 1036
July 28 – August 1
We are thrilled to be participating in the Alzheimer’s Association International Conference (AAIC), the world’s largest forum for the dementia research community.
Visit us at booth 1036, and mark your calendar for our scientific sessions to experience how the power of the SomaScan Platform can advance your novel biomarker discoveries.
Alzheimer’s Association International Conference Scientific Sessions 2024
ABSTRACT ORAL SESSION
Novel dementia biomarkers and disease mechanisms identified in blood
Keenan Walker, PhD, Chief, Multimodal Imaging of Neurodegenerative Disease (MIND) Unit, Laboratory of Behavioral Neuroscience, National Institute on Aging, Intramural Research Program
Wednesday, July 31 | 10:30–11:00am
This presentation will describe how proteomic, MRI, and PET neuroimaging have been used in concert with risk factor assessment to understand – at a molecular level – how aberrations in immune function influence risk for neurodegenerative disease.
POSTER SESSION
Poster #95359: A proteomic predictor of conversion to dementia from mild cognitive impairment with potential utility in enhancing productivity of emerging clinical trials
Presented by Clare Paterson, Director, Clinical R&D, Standard BioTools
Monday, July 29 | 3:30-4:15pm
View the conference agenda and learn more about the event on the AAIC website.